Dedicator of Cytokinesis 4: A Potential Prognostic and Predictive Biomarker Within the Metastatic Spread of Breast Cancer to Bone
Metastasis to bone occurs in over 70% of patients with advanced breast cancer resulting in skeletal complications, including pathological fractures, hypercalcaemia, and bone pain. Significant advances have been made in the treatment of bone metastases, including the use of antiresorptive drugs, such...
Main Authors: | Janet E Brown, Jules A Westbrook, Steven L Wood |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-08-01
|
Series: | Cancer Informatics |
Online Access: | https://doi.org/10.1177/1176935119866842 |
Similar Items
-
Wiskott-Aldrich Syndrome (WAS) and Dedicator of Cytokinesis 8- (DOCK8) Deficiency
by: Michael H. Albert, et al.
Published: (2019-11-01) -
Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases
by: Steven L. Wood, et al.
Published: (2020-07-01) -
Hyper IgE Syndrome Associated With Warts: A First Case of Dedicator of Cytokinesis 8 Deficiency in the Philippines
by: Jose Carlo Miguel M. Villanueva, et al.
Published: (2020-10-01) -
Dedicator of cytokinesis 8 mutation related combined immune deficiency: A single centre experience from India
by: Dhwanee Thakkar, et al.
Published: (2017-10-01) -
SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast Cancer
by: Lauren L. Siewertsz van Reesema, et al.
Published: (2016-09-01)